PAVmed Inc. PAVM
Rating
Rating Factors
Company Overview
PAVmed Inc. is a diversified commercial-stage medical technology company focused on developing, acquiring, and commercializing healthcare products and technologies across multiple clinical areas. The company operates primarily in the medical device and digital health industries, with activities spanning minimally invasive technologies, diagnostics, cancer detection, and healthcare infrastructure solutions. PAVmed’s business model combines internal product development with majority-controlled subsidiaries that pursue targeted commercialization strategies in specialized healthcare markets.
The company’s primary revenue drivers and strategic focus have centered on its ownership interests in Lucid Diagnostics Inc., which develops esophageal precancer detection technologies, and Veris Health Inc., a digital health and remote patient monitoring platform. Historically, PAVmed also developed products in areas such as infusion therapy and gastrointestinal technologies. Founded in 2014 by medical device entrepreneur Lishan Aklog, the company evolved from a single-product development platform into a holding-company-style healthcare technology organization with multiple operating subsidiaries and public market financing relationships.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $3.70
- Current
- $3.85
- High
- $28.44
Valuation
Dividends and Shares
Corporate Info
25th Floor
New York, NY 10017